Bio-Rad Laboratories, Inc.
BIO· NYSE
BIOBio-Rad Laboratories, Inc.
Filed Aug 2, 2024 · 10-Q · 33 days after period end · 0000012208-24-000052
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $638.50M | $681.11M | $691.10M | $715.93M |
| Net Income | -$2.17B | -$1.16B | -$925.10M | $916.80M |
| EPS Diluted | -$76.26 | -$39.59 | -$31.05 | $30.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 2, 2024 · 33 d after period end
